Key facts
- It has raised $13.7M; the latest was Early Stage VC ($13.7M) in Apr 2025.
- Notable investors include Lapam Capital, Dalton Venture, LAV (Lilly Asia Fund), Shanghai Yinglian Health Industry Equity Investment, Tianrui Fengnian.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for United InnoMed
- ·The full record, as it builds
Funding rounds
No funding rounds for United InnoMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About United InnoMed
Provider and developer of active implantable medical devices designed for heart failure. The company focuses on heart failure management system and sensor device manufacturing, enabling clients with implantable medical devices.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2020
- Ownership
- Privately Held (backing)
United InnoMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in United InnoMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on United InnoMed in its N-PORT filings yet. We sweep new filings monthly.